VR Logo

Gufic Biosciences Ltd.

Add to My Investments

Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

Get the Stocks!

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1984

Chairman: Jayesh P Choksi

Managing Director: Jayesh P Choksi

Group: --

Listing: NSE: GUFICBIO, BSE: 509079

Headquarters: Mumbai, Maharashtra

Website: www.gufic.com

Key Facts

Market cap: R 915.28 Cr

Revenue (TTM): R 353.83 Cr

Earnings (TTM): R 24.33 Cr

Cash: R 10.82 Cr

Total Debt: R 110.73 Cr

Promoters' ownership: 65.75%

Liquidity: High

52 Week range: R 37.00 - 137.45

Face value: R1.00

Shares outstanding: 7,78,30,000

10 Years Aggregate:

  • CFO: 71.12 Cr
  • EBITDA: 222.50 Cr
  • Net Profit: 92.36 Cr

Stock Performance

Time Period Gufic Biosciences S&P BSE Healthcare S&P BSE Small Cap
YTD0.56-1.601.79
1 month3.201.417.62
3 months31.108.4622.58
1 Year90.8852.3525.89
3 Years-2.6412.53-2.06
5 Years25.526.5311.68
10 Years34.3012.557.48
As on 22-Jan-2021
Year Gufic Biosciences S&P BSE Small Cap S&P BSE Healthcare
202093.4732.1161.45
2019-35.40-6.85-3.55
2018-26.15-23.41-5.89
2017138.2559.640.49
2016-4.491.77-12.88
2015225.156.7615.06